Tokyo, Japan - February 2, 2023
Yokogawa Electric Corporation (TOKYO: 6841) announces the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. Since signing investment and collaboration agreements in August 2021, the two companies have been exploring potential business opportunities. Through this acquisition, Fluence Analytics will integrate its operations with Yokogawa's existing business and further enhance its technological capabilities. Starting today, Fluence Analytics will operate as Yokogawa Fluence Analytics.
Fluence Analytics is a global leader in polymerization*1 reaction monitoring and control, and its automatic continuous online monitoring of polymerizations (ACOMP) product is the only commercially available system that can measure and analyze multiple polymer properties in real time. ACOMP's data streams provide new insights into material properties that enable customers to optimize and control polymerization processes, leading to improved product quality, greater yields, and less energy consumption and material waste. Based on the average size of a polymer reactor, the ACOMP system is estimated to deliver US$1.5 million in value per year*2.
Initial agreements between the two companies in August 2021 generated strong interest from global chemical companies seeking to transform their operations with automated digital technologies. Fluence Analytics is currently developing the next-generation ACOMP product, which will become part of Yokogawa's OpreX offering. The two companies are exploring how to integrate the next-generation ACOMP with Yokogawa's advanced control solutions and the digital technologies of KBC, another Yokogawa Group company. Yokogawa's global network will perform engineering and system integration tasks and provide after-sales field services for the ACOMP system.
Kenji Hasegawa, a Yokogawa Electric vice president and head of the Yokogawa Products Headquarters, commented, “Polymers are used in nearly every aspect of modern society in the form of plastics, rubber, paint, and so on. Combining Fluence Analytics' ACOMP system and other technology with our industry know-how will enable us to work with our customers to digitalize and automate polymerization processes that are currently monitored and adjusted manually. This will assist customers to improve worker safety, profitability, and environmental performance. We also plan to apply this technology to polymer re-use. We believe this is truly a game-changer for the industry.”
In addition to ACOMP, the Fluence Analytics product portfolio includes an innovative lab instrument designed to dramatically accelerate and optimize the development of novel biotherapeutics. The instrument enables the rapid assessment and real-time monitoring of the stability of therapeutic proteins, peptides, and other biopolymers under various thermal, mechanical, and chemical stress conditions.
“Combining forces with Yokogawa Electric enables us to capture the full value of our unique data sets, and we can't wait to deliver this added value to our customers. Together, we will enable autonomous operations and digital transformation in the polymer and biopharma industries,” says Jay Manouchehri, CEO of Yokogawa Fluence Analytics.
*1 The combination of small molecules, called monomers, to form larger molecules (polymers)
*2 Estimation by Fluence Analytics based on the following operating conditions: Annual production 15,000 tons (300 batches/year, 50 tons per batch), USD 3,000 per ton.
Outline of Fluence Analytics, Inc.
Headquarters: Stafford, Texas, USA
CEO: Jay Manouchehri
Number of employees: 25
Business: Developing and providing real-time industrial and laboratory analytics solutions for polymer and biopharmaceutical companies
Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.
Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 122 companies spanning 61 countries. For more information, visit www.yokogawa.com
The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.
Chemical plants rely on continuous and batch production processes, each posing different requirements for a control system. A continuous process calls for a robust and stable control system that will not fail and cause the shutdown of a production line, whereas the emphasis with a batch process is on having a control system that allows great flexibility in making adjustments to formulas, procedures, and the like. Both kinds of systems need to be managed in available quality history of product, and to be able to execute non-routine operations. With its extensive product portfolio, experienced systems engineers, and global sales and service network, Yokogawa has a solution for every plant process.
The pharmaceutical industry currently faces a major challenge in taking full advantage of the opportunities presented in large emerging markets. Now, more than ever, pharmaceutical companies need to introduce lean manufacturing techniques that will enhance profitability. As one of the world's leading industrial automation suppliers, Yokogawa is committed to delivering the best possible solutions for your best manufacturing practices.